98 related articles for article (PubMed ID: 22828589)
1. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
[TBL] [Abstract][Full Text] [Related]
2. Rapid loss of vaccine-acquired hepatitis B surface antibody after three doses of hepatitis B vaccination in HIV-infected persons.
Mizusawa M; Perlman DC; Lucido D; Salomon N
Int J STD AIDS; 2014 Mar; 25(3):201-6. PubMed ID: 24216032
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count.
Landrum ML; Huppler Hullsiek K; Ganesan A; Weintrob AC; Crum-Cianflone NF; Barthel RV; Peel S; Agan BK
Vaccine; 2009 Jul; 27(34):4731-8. PubMed ID: 19540026
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus vaccination in HIV-infected people: A review.
Catherine FX; Piroth L
Hum Vaccin Immunother; 2017 Jun; 13(6):1-10. PubMed ID: 28267387
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.
Landrum ML; Hullsiek KH; Ganesan A; Weintrob AC; Crum-Cianflone NF; Barthel RV; O'Connell RJ; Fieberg A; Chun HM; Marconi VC; Dolan MJ; Agan BK;
AIDS; 2010 Feb; 24(4):545-55. PubMed ID: 19487908
[TBL] [Abstract][Full Text] [Related]
6. Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
Chaparro M; Gordillo J; Domènech E; Esteve M; Barreiro-de Acosta M; Villoria A; Iglesias-Flores E; Blasi M; Naves JE; Benítez O; Nieto L; Calvet X; García-Sánchez V; Villagrasa JR; Marin AC; Donday MG; Abad-Santos F; Gisbert JP
Am J Gastroenterol; 2020 Nov; 115(11):1802-1811. PubMed ID: 33156099
[TBL] [Abstract][Full Text] [Related]
7. Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine.
Pasricha N; Datta U; Chawla Y; Singh S; Arora SK; Sud A; Minz RW; Saikia B; Singh H; James I; Sehgal S
BMC Infect Dis; 2006 Mar; 6():65. PubMed ID: 16571140
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Accelerated and Standard Hepatitis B Vaccination Schedules in High-Risk Healthy Adults: A Meta-Analysis of Randomized Controlled Trials.
Jin H; Tan Z; Zhang X; Wang B; Zhao Y; Liu P
PLoS One; 2015; 10(7):e0133464. PubMed ID: 26196903
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B vaccine antibody response and the risk of clinical AIDS or death.
Landrum ML; Hullsiek KH; O'Connell RJ; Chun HM; Ganesan A; Okulicz JF; Lalani T; Weintrob AC; Crum-Cianflone NF; Agan BK;
PLoS One; 2012; 7(3):e33488. PubMed ID: 22457767
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses during hepatitis B viral infection.
Ciupe SM; Ribeiro RM; Perelson AS
PLoS Comput Biol; 2014 Jul; 10(7):e1003730. PubMed ID: 25078553
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals.
Azzoni L; Foulkes AS; Firnhaber C; Yin X; Xiang ZQ; Li Y; Stevens W; Gross R; Ertl HC; Sanne I; Montaner LJ
AIDS; 2012 Jul; 26(11):1355-62. PubMed ID: 22516873
[TBL] [Abstract][Full Text] [Related]
12. Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.
Crum-Cianflone NF; Wilkins K; Lee AW; Grosso A; Landrum ML; Weintrob A; Ganesan A; Maguire J; Klopfer S; Brandt C; Bradley WP; Wallace MR; Agan BK;
J Infect Dis; 2011 Jun; 203(12):1815-23. PubMed ID: 21606540
[TBL] [Abstract][Full Text] [Related]
13. Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions.
Cagigi A; Cotugno N; Giaquinto C; Nicolosi L; Bernardi S; Rossi P; Douagi I; Palma P
Hum Vaccin Immunother; 2012 Dec; 8(12):1784-94. PubMed ID: 22906931
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Disease Burden and Immunization Rates for Vaccine-Preventable Diseases in People Living with HIV: The Korea HIV/AIDS Cohort Study.
Seong H; Choi Y; Ahn KH; Choi JY; Kim SW; Kim SI; Kee MK; Choi BY; Park B; Hyun HJ; Yoon JG; Noh JY; Cheong HJ; Kim WJ; Song JY
Infect Chemother; 2023 Dec; 55(4):441-450. PubMed ID: 37674339
[TBL] [Abstract][Full Text] [Related]
15. Multi-Omic Data Integration Allows Baseline Immune Signatures to Predict Hepatitis B Vaccine Response in a Small Cohort.
Shannon CP; Blimkie TM; Ben-Othman R; Gladish N; Amenyogbe N; Drissler S; Edgar RD; Chan Q; Krajden M; Foster LJ; Kobor MS; Mohn WW; Brinkman RR; Le Cao KA; Scheuermann RH; Tebbutt SJ; Hancock REW; Koff WC; Kollmann TR; Sadarangani M; Lee AH
Front Immunol; 2020; 11():578801. PubMed ID: 33329547
[TBL] [Abstract][Full Text] [Related]
16. Hemodialysis and hepatitis B vaccination: a challenge to physicians.
Ayub MA; Bacci MR; Fonseca FL; Chehter EZ
Int J Gen Med; 2014; 7():109-14. PubMed ID: 24520201
[TBL] [Abstract][Full Text] [Related]
17. Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil.
Ferri LP; Junqueira PDS; de Almeida MMS; Oliveira MG; de Oliveira BR; Diniz E Silva BV; Magalhães LS; Villar LM; Caetano KAA; Souza MM; Carneiro MADS; Martins RMB; Teles SA
Trop Med Infect Dis; 2022 Sep; 7(10):. PubMed ID: 36288010
[TBL] [Abstract][Full Text] [Related]
18. Delays in Hepatitis B Immunization Series Completion in People With Human Immunodeficiency Virus.
Sheikh D; Staggers KA; Carey J; Keitel WA; Atmar RL; El Sahly HM; Whitaker JA
Open Forum Infect Dis; 2023 Nov; 10(11):ofad543. PubMed ID: 38033987
[TBL] [Abstract][Full Text] [Related]
19. HIV Universal Vaccine.
Malecki M; Saetre B
Mol Cell Ther; 2018 Apr; 6(1):. PubMed ID: 30815266
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of hepatitis A antibody after immunization with hepatitis A vaccine (Aimmugen) in people living with HIV.
Koga M; Saito M; Kubota M; Senkoji T; Adachi E; Ikeuchi K; Kikuchi T; Otani A; Takahashi K; Tsutsumi T; Yotsuyanagi H
Hepatol Res; 2024 May; 54(5):487-494. PubMed ID: 38263905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
